In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Toon Wei Lim
Toon Wei Lim
Toon Wei Lim Toon Wei Lim

National University Hospital, Singapore (Singapore)

Specialities : Arrhythmias-General , e-Cardiology, Cardiovascular Disease in Primary Care

Dr Toon Wei Lim is a senior consultant cardiologist at the National University Heart Centre, Singapore and specialises in cardiac electrophysiology. He graduated from the University of Sydney in 1997 with 1st Class Honours and was awarded a PhD from the University of Sydney for his research on atrial fibrillation ablation. In 2009 he joined the University of Ottawa Heart Institute as a Clinical Fellow in Cardiac Electrophysiology before returning to his hometown in 2010 to join the Arrhythmia Service of the National University Heart Centre, Singapore. Dr Lim’s main research interest is in device and drug therapy for cardiac arrhythmias. He has also been working on integrated chronic care for patients with atrial fibrillation with a focus on patient education and self-management. For the past 4 years, he has also served on the executive council of the Singapore Cardiac society and is currently the Vice President.

4 presentations from this speaker

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are